BioSpace News Archive

Medikine, Inc., a privately-held biopharmaceutical company focused on the discovery and development of cytokine mimetics for the treatment of cancer, autoimmune disorders, and infectious diseases, announced that it will deliver a poster presentation at the AACR Annual Meeting 2022.

The Multiple Sclerosis Society of Canada announced a nearly $1.35 million investment from Biogen Canada Inc., Hoffmann-La Roche Limited, and Brain Canada Foundation towards a new sub-cohort of the Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis that follows pediatric-onset MS participants from the Canadian Pediatric Demyelinating Disease Study as they become adults to understand MS across the age-span.

According to a new study conducted by GSK, people age 50 or older in the US who have had COVID-19 may be at greater risk of developing shingles – a painful rash – compared to those who haven’t been diagnosed with COVID-19.

Rising prevalence of cancer across the globe and rise in investments in research & development of effective cancer therapies are among the key factors driving market revenue growth.

The industry analysis report is considered a valuable source of information about the global Optogenetics industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

Abivax SA today reports excellent results from the Interim Analysis of its phase 2b open-label maintenance study, including 217 patients who completed the one year of once-daily oral treatment with 50mg ABX464.

As part of Aatru Medical, LLC (“Aatru”) commercial planning, the company is pleased to announce a Latin America distribution agreement with Salus Biomedical, for the NPSIMS product.

The global pulmonary arterial hypertension market size is predicted to be worth around USD 10.9 billion by 2030 from valued at USD 6.9 billion in 2020, growing at a CAGR of 5.1% from 2022 to 2030.

The global healthcare software as a service market size is expected to hit around USD 60.7 billion by 2030 from valued at USD 12.2 billion in 2020 with a CAGR of 20.5% from 2022 to 2030.

Aidoc, the leading provider of healthcare AI solutions, announced today that it received its 9th FDA 510(k) clearance for triage and notification of brain aneurysm.